Balance Sheet
Cash Flow Statement
Amortization of GoodwillAmortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Onconetix (ONCO) Free Cash Flow (2023 - 2025)

Onconetix (ONCO) has disclosed Free Cash Flow for 2 consecutive years, with -$925705.0 as the latest value for Q4 2024.

  • On a quarterly basis, Free Cash Flow fell 152.46% to -$925705.0 in Q4 2024 year-over-year; TTM through Dec 2024 was -$10.5 million, a 22.5% increase, with the full-year FY2024 number at -$10.5 million, up 22.5% from a year prior.
  • Free Cash Flow was -$925705.0 for Q4 2024 at Onconetix, up from -$1.1 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of $1.8 million in Q4 2023 to a low of -$7.9 million in Q2 2023.